Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains
- PMID: 14615871
- DOI: 10.1007/s00213-003-1553-4
Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains
Abstract
Rationale: Schizophrenia is a heterogeneous syndrome both at the etiological and clinical levels. In particular, patients with schizophrenia exhibit important variability in their therapeutic and metabolic responses to clozapine, an antipsychotic medication.
Objective: Here, we determine whether two mouse strains show differing clozapine responses with respect to weight gain, enhancement of prepulse inhibition of acoustic startle, and reversal of amphetamine-induced locomotion. Observed between-strain differences may be partly due to genetic factors that can be subsequently mapped using quantitative genetic approaches.
Methods: We treated the A/J and C57BL/6J inbred mouse strains with clozapine for 22 days. Prepulse inhibition and amphetamine-induced locomotion were measured after 3-4 days of clozapine treatment and again after 21-22 days of treatment. Weight gain was also monitored during treatment. RESULTS. Three-day treatment with clozapine increased prepulse inhibition in both strains. Four-day clozapine treatment reduced amphetamine-induced locomotion only in the C57BL/6J strain. Long-term (21-22 days) clozapine treatment did not affect these behaviors in either strain. After an initial weight loss during the first 5 days, clozapine (4 mg/kg) induced a significant weight gain in both strains.
Conclusions: The reversal of schizophrenia-related behaviors after short-term, but not long-term, clozapine treatment is consistent with other rodent studies. Although short-term clozapine treatment reduced amphetamine-induced locomotion only in the C57BL/6J strain, strain differences in amphetamine responses confound the interpretation of these results; therefore, quantitative genetic approaches may be difficult to carry out with this trait. In contrast, enhancement of prepulse inhibition after three days of clozapine treatment and weight gain induced by clozapine are relatively straightforward to quantify, making these trait more amenable to quantitative genetic approaches.
Similar articles
-
Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice.Psychopharmacology (Berl). 2009 Nov;206(4):677-98. doi: 10.1007/s00213-009-1568-6. Epub 2009 May 30. Psychopharmacology (Berl). 2009. PMID: 19484222
-
Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.Psychopharmacology (Berl). 2006 Jan;184(2):190-200. doi: 10.1007/s00213-005-0214-1. Epub 2005 Dec 16. Psychopharmacology (Berl). 2006. PMID: 16362405
-
Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.Psychopharmacology (Berl). 2007 Sep;194(1):93-102. doi: 10.1007/s00213-007-0824-x. Epub 2007 May 31. Psychopharmacology (Berl). 2007. PMID: 17541558
-
Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.J Clin Psychiatry. 2001;62 Suppl 23:45-66. J Clin Psychiatry. 2001. PMID: 11603885 Review.
-
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.Psychopharmacology (Berl). 1997 Jul;132(2):107-24. doi: 10.1007/s002130050327. Psychopharmacology (Berl). 1997. PMID: 9266608 Review.
Cited by
-
Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.Physiol Behav. 2011 Sep 26;104(4):590-8. doi: 10.1016/j.physbeh.2011.05.033. Epub 2011 Jun 12. Physiol Behav. 2011. PMID: 21664918 Free PMC article. Review.
-
Animal models of eating disorders.Neuroscience. 2012 Jun 1;211:2-12. doi: 10.1016/j.neuroscience.2012.03.024. Epub 2012 Mar 21. Neuroscience. 2012. PMID: 22465439 Free PMC article. Review.
-
Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculus.Brain Res. 2011 Jun 1;1393:91-9. doi: 10.1016/j.brainres.2011.04.010. Epub 2011 Apr 9. Brain Res. 2011. PMID: 21529784 Free PMC article.
-
Animal models of gene-environment interactions in schizophrenia.Behav Brain Res. 2009 Dec 7;204(2):274-81. doi: 10.1016/j.bbr.2009.04.010. Epub 2009 Apr 18. Behav Brain Res. 2009. PMID: 19379776 Free PMC article.
-
A parametric analysis of olanzapine-induced weight gain in female rats.Psychopharmacology (Berl). 2005 Aug;181(1):80-9. doi: 10.1007/s00213-005-2224-4. Epub 2005 Oct 15. Psychopharmacology (Berl). 2005. PMID: 15778884
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical